Fenwick & West LLP represented San Diego, CA based DexCom, Inc. (Nasdaq: DXCM) in its initial public offering. DexCom is a leading developer of sensor technology for the continuous monitoring of glucose in people with diabetes. The offering raised over $56 million for DexCom, which issued 4,700,000 shares of common stock in the offering. The offering was underwritten by lead manager Piper Jaffray & Co. SG Cowen & Co., LLC was the co-lead manager. William Blair & Company, L.L.C. and First Albany Capital Inc. acted as co-managers.
Inquiries related to this transaction may be directed to Gordon Davidson, Chairman of Fenwick & West, at 650.335.7237 or email@example.com.